CD276 and neoplasm: We found high mRNA levels in four immune checkpoints related genes, namely CD24, CD276 (B7-H3), CD47, and PVR, and when compared with non-tumor tissue, we confirmed the selective higher tumor expression of CD24 and CD276. Notably, there are two ongoing clinical trials targeting B7-H3.